General Information Job Advert Title: 開発適性評価リード、Analytical Development Lead, Pharmaceutical Developability Location: Tsukuba, Ibaraki Division: Product Research & Development Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into VALUE
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236),
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236),
JOB DESCRIPTION: About Abbott Abbott is a global healthcare leader, creating breakthrough science to improve people’s health. We’re always looking towards the future, anticipating changes in medical science and technology. Working at Abbott At Abbott, you
Key Account Manager (KAM) Location: Saitama to Nothern Kanto Department: Sales Job type: Full Time Join us and make a difference when it matters most! At Mundipharma, we are proud of the work we do to
General Information Job Advert Title: Scientist, Analytical Research 3, Analytical Research Labs, Product Research & Development Location: Tsukuba, Ibaraki Division: Product Research & Development Employment Class: Permanent Description 【募集の背景 / Purpose & Scope】 Product characterization, analytical
ジェンマブは革新的な抗体医薬の開発に注力し、患者さんの生活を改善することに力を尽くしています。 私たちは、extra[not]ordinary® な未来を共に築くことを使命とし、革新的な抗体製品の開発や人々を感動させる抗体医薬品で、がんやその他の深刻な病に苦しむ患者さんの生活を根本的に変え、治療の未来を切り拓いています。 ジェンマブは思いやりがあり、率直で、患者さんに貢献したいという強い思いを持った人たちがともに働き、科学に基づく変化をもたらします。大胆さと高潔性を持って行動し、新しい未来をつくることを目指すこと が、この使命を果たすために不可欠だと信じています。 私たちは大きな志を掲げ、楽しく、そして思いやりの心を忘れずに、日々意義のある仕事に取り組んでいます。私たちは、個々のユニークな貢献を受け入れ、それらを原動力として、患者、ケアパートナー、ご家族、そして社員のニーズを満たす革新的なソリューションを生み出し、育み、維持するグローバルな企業文化の構築に努めています。 私たちの想いに共鳴し、自分らしく活躍できそうだと感じたら、ぜひ一緒に働きましょう。 Position Summary: The Medical Science Liaison (MSL) is a field-based expert who, under the vision of “leading medical transformation together with healthcare professionals (HCPs) through science,” operates through a
COMPANY DESCRIPTION: A career here is life-enhancing. At Syner-G, we enable our people to build careers that impact positively on their quality of life. Through our expertise, insight, consulting and management skills, we accelerate breakthrough science and
General Information Job Advert Title: 【つくば】原薬プロセス研究（ラボオートメーション）サイエンティスト Location: Tskuba, Ibaraki Employment Class: Permanent Description 【募集の背景 / Purpose & Scope】 合成系、バイオベース、およびハイブリッドプラットフォームを含むCMC関連のプロセス技術を特定・評価・優先順位付けし、他のCMCラボと連携して導入する。 ラボオートメーションおよびデジタル技術の導入・運用を通じて、CMCバイオ医薬品プロセス開発における「CMCラボオートメーションおよびDX」コンセプトの現場実装を推進する。 本ポジションでは、チームリーダーやマネージャーの適度なサポートを受けながら、これらの活動を主体的に実行することが求められる。 Identify, assess, and prioritize CMC related process technologies, including synthetic, bio-based, and hybrid platforms and
Location: You will primarily work in the Chiba area. Your residence is expected to be in Chiba or Tokyo. Are you ready to make a meaningful impact in the pharmaceutical industry? At Regeneron, we’re committed to putting
企業概要 シンテゴンテクノロジーは、医薬品・食品の製造プロセス・包装機械のリーディングサプライヤーです。 ボッシュの包装機械事業部であったボッシュパッケージングテクノロジーとして、50年に渡り医薬品および食品分野における技術を中心に事業を展開し、2020年1月からは、ヴァイブリンゲン（ドイツ）に本社をもつ企業、シンテゴンテクノロジーとして独立しました。 シンテゴンテクノロジーは、世界15か国以上で30を超える拠点を構え、従業員数はグローバルで合計6,100名に上り、2019年の売上は13億ユーロとなりました。医薬品向け検査技術においては、“Center of Competence” として当社日本法人がワールドワイドの開発をリードしています。 Syntegon Technology is a leading global process and packaging technology provider. Around 5,800 colleagues in more than 15 countries work for the Syntegon Group on intelligent and sustainable technologies
JOB DESCRIPTION: Primary Function Provides global or regional leadership for a particular regional or global clinical program. Ensures design and execution of high quality clinical studies to ensure safety and effectiveness of the company’s products. Manages clinical
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236),
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236),
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236),
General Information Job Advert Title: 【つくば】分析開発サイエンティスト・外部製造技術統括（SME） Location: Tokodai, Ibaraki Division: External Manufacturing Employment Class: Permanent Description Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives
At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives